Pharma Journalist -

Antiverse Ltd (Antiverse), a biotechnology company developing a computational antibody drug discovery platform, and GlobalBio, Inc. (GlobalBio), an antibody engineering company…
Read More...

LegoChem Biosciences Inc. (LCB) and Glycotope GmbH (Glycotope) have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate (ADC) by combining…
Read More...

Novo Nordisk A/S and KBP Biosciences PTE., Ltd. announced that Novo Nordisk has agreed to acquire ocedurenone for uncontrolled hypertension with potential application in cardiovascular…
Read More...

Vaxcyte, Inc., a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, and Lonza, a global…
Read More...

Almirall S.A., a global biopharmaceutical company focused on medical dermatology, today announced the presentation of new data on lebrikizumab through 18 abstracts, including two oral…
Read More...

Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) + MEKTOVI (binimetinib) for the treatment of adult patients with metastatic…
Read More...

MimiVax, Inc., a biotechnology company focused on the development of glioblastoma vaccine therapy, announced that the United States Food and Drug Administration (FDA) has granted Fast…
Read More...

See full summit details here. Over the past year, the allogeneic cell therapy landscape has continued to evolve. Amidst the clinical and commercial developments, the challenging…
Read More...

Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that global…
Read More...

Bayer has opened a new cell therapy manufacturing facility in Berkeley, California, USA, to offer cell therapies to patients worldwide. The $250 million investment will be used to…
Read More...